{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:30Z","timestamp":1791273090922,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biosci"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s12038-008-0078-8","type":"journal-article","created":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T02:11:52Z","timestamp":1229998312000},"page":"605-616","source":"Crossref","is-referenced-by-count":70,"title":["Multidrug resistant to extensively drug resistant tuberculosis: What is next?"],"prefix":"10.1007","volume":"33","author":[{"given":"Amita","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"78_CR1","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1136\/bmj.38645.660093.68","volume":"331","author":"R. Baltussen","year":"2005","unstructured":"Baltussen R, Floyd K and Dye C 2005 Cost effectiveness analysis of strategies for tuberculosis control in developing countries; Br. Med. J.\n331 1364","journal-title":"Br. Med. J."},{"key":"78_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"H. M. Blumberg","year":"2003","unstructured":"Blumberg H M, Burman W J, Chaisson R E, Daley C L, Etkind S C, Friedman L N, Fujiwara P, Grzemska M, et al 2003 American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis; Am. J. Respir. Crit. Care Med.\n167 603\u2013662","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78_CR3","first-page":"1405","volume":"15","author":"E. Bouvet","year":"2007","unstructured":"Bouvet E 2007 Multidrug resistant tuberculosis: What is the risk in France?; Rev. Prat.\n15 1405\u20131408","journal-title":"Rev. Prat."},{"key":"78_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/arrd.1983.128.3.578a","volume":"128","author":"J. L. Carpenter","year":"1983","unstructured":"Carpenter J L, Obnibene A J, Gorby E W, Neimes R E, Koch J and Perkins W L 1983 Antituberculosis drug resistance in south Texas; Am. Rev. Respir. Dis.\n128 1055\u20131058","journal-title":"Am. Rev. Respir. Dis."},{"key":"78_CR5","first-page":"301","volume":"55","author":"Centers for Disease ControlPrevention","year":"2006","unstructured":"Centers for Disease Control and Prevention 2006 Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide; MMWR\n55 301\u2013305","journal-title":"MMWR"},{"key":"78_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/bmj.325.7375.1282","volume":"325","author":"E. D. Chan","year":"2002","unstructured":"Chan E D and Iseman M D 2002 Current medical treatment for tuberculosis; Br. Med. J.\n325 1282\u20131286","journal-title":"Br. Med. J."},{"key":"78_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0962-8479(93)90008-L","volume":"74","author":"M. Datta","year":"1993","unstructured":"Datta M, Radhamani M P, Selvaraj R, Paramasivan C N, Gopalan B N, Sudeendra C R and prabhakar R, et al 1993 Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme; Tuber. Lung Dis.\n74 180\u2013186","journal-title":"Tuber. Lung Dis."},{"key":"78_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0140-6736(05)74812-1","volume":"365","author":"K. DeRiemer","year":"2005","unstructured":"DeRiemer K, Garcia-Garcia L and Bobadilla-del-Valle M 2005 Does DOTS work in populations with drug-resistant tuberculosis?; Lancet\n365 1239\u20131245","journal-title":"Lancet"},{"key":"78_CR9","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S1201-9712(02)90151-7","volume":"6","author":"F. A. Drobniewski","year":"2002","unstructured":"Drobniewski F A and Balabanova Y M 2002 The diagnosis and management of multiple-drug-resistant tuberculosis at the beginning of the new millennium; Int. J. Infect. Dis.\n6 S21\u2013S31","journal-title":"Int. J. Infect. Dis."},{"issue":"23","key":"78_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/thorax.57.9.810","volume":"57","author":"F. Drobniewski","year":"2002","unstructured":"Drobniewski F, Eltringham I, Graham C, Magee J G, Smith E G and Watt B 2002 A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK; Thorax\n5723 810\u2013816","journal-title":"Thorax"},{"key":"78_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0140-6736(07)60466-8","volume":"369","author":"Editorial","year":"2007","unstructured":"Editorial 2007 Stopping tuberculosis proves hard to do; Lancet\n369 965","journal-title":"Lancet"},{"key":"78_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0140-6736(05)74788-7","volume":"365","author":"M. A. Espinal","year":"2005","unstructured":"Espinal M A and Dye C 2005 Can DOTS control multidrug-resistant tuberculosis?; Lancet\n365 1206\u20131209","journal-title":"Lancet"},{"key":"78_CR13","first-page":"561","volume":"3","author":"M. A. Espinal","year":"1999","unstructured":"Espinal M A, Dye C, Raviglione M, et al 1999 Rational \u2018DOT plus\u2019 for the control of MDR-TB; Int. Tuberc. Lung Dis.\n3 561\u2013563","journal-title":"Int. Tuberc. Lung Dis."},{"key":"78_CR14","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","volume":"283","author":"M. A. Espinal","year":"2000","unstructured":"Espinal M A, Kim S J, Suarez P G, et al 2000 Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA\n283 2537\u20132545","journal-title":"JAMA"},{"key":"78_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/bmj.317.7159.671","volume":"317","author":"P. Farmer","year":"1998","unstructured":"Farmer P and Kim J Y 1998 Community based approaches to the control of multidrug resistant tuberculosis: introducing \u201cDOTS-plus\u201d; Br. Med. J.\n317 671\u2013674","journal-title":"Br. Med. J."},{"key":"78_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1164\/ajrccm.160.2.9901012","volume":"160","author":"M. Flament-Saillour","year":"1999","unstructured":"Flament-Saillour M, Robert J, Jarlier V, et al 1999 Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study; Am. J. Respir. Crit. Care Med.\n160 587\u2013593","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78_CR17","first-page":"43","volume":"84","author":"K. Floyd","year":"2006","unstructured":"Floyd K, Hutubessy R, Samyshkin E, et al 2006 Health-systems efficiency in the Russian Federation: tuberculosis control. Bull.WHO\n84 43\u201351","journal-title":"Bull.WHO"},{"key":"78_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"N. R. Gandhi","year":"2006","unstructured":"Gandhi N R, Moll A and Sturm A W 2006 Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa; Lancet\n368 1575\u20131580","journal-title":"Lancet"},{"key":"78_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jac\/dkh377","volume":"54","author":"Giovanni Di PerriStefano Bonora","year":"2004","unstructured":"Giovanni Di Perri and Stefano Bonora 2004 Which agents should we use for the treatment of multidrug- resistant Mycobacterium tuberculosis?; J. Antimicrob. Chemother.\n54 593\u2013602","journal-title":"J. Antimicrob. Chemother."},{"key":"78_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1056\/NEJM199302253280802","volume":"328","author":"M. Goble","year":"1993","unstructured":"Goble M, Iseman M D, Madsen L A, et al 1993 Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin; N. Engl. J. Med.\n328 527\u2013532","journal-title":"N. Engl. J. Med."},{"key":"78_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1046\/j.1365-3156.2002.00960.x","volume":"7","author":"R. Gupta","year":"2002","unstructured":"Gupta R, Cegielski J P, Espinal M A, et al 2002 Increasing transparency for health: introducing the Green Light Committee; Trop. Med. Int. Health\n7 970\u2013976","journal-title":"Trop. Med. Int. Health"},{"key":"78_CR22","first-page":"410","volume":"7","author":"R. Gupta","year":"2003","unstructured":"Gupta R and Espinal M and Stop TB Working Group on DOTS-Plus for MDR-TB 2003 A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB); Int. J. Tuberc. Lung Dis.\n7 410\u2013414","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR23","first-page":"1078","volume":"5","author":"R. Gupta","year":"2001","unstructured":"Gupta R, Raviglione and Espinal M A 2001 Should tuberculosis programmes invest in second line treatments for multidrug-resistant tuberculosis (MDR-TB)?; Int. J. Tuberc. Lung Dis.\n5 1078\u20131079","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR24","first-page":"564","volume":"3","author":"L. B. Heifets","year":"1999","unstructured":"Heifets L B and Cangelosi G A 1999 Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century; Int. J. Tuberc. Lung Dis.\n3 564\u2013581","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR25","first-page":"S258","volume":"9","author":"T. H. Holtz","year":"2005","unstructured":"Holtz T H, Riekstina V, Zarovska E, et al 2005 XDR-TB: extreme drug-resistance and treatment outcome under DOTS-Plus, Latvia, 2000\u20132002; Int. J. Tuberc. Lung Dis. (Suppl. 1)\n9 S258","journal-title":"Int. J. Tuberc. Lung Dis. (Suppl. 1)"},{"key":"78_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S1473-3099(06)70628-4","volume":"6","author":"P. C. Hopewell","year":"2006","unstructured":"Hopewell P C, Pai M, Maher D, et al 2006 International standards for Tuberculosis care; Lancet Infect. Dis.\n6 710\u2013725","journal-title":"Lancet Infect. Dis."},{"key":"78_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1086\/507906","volume":"194","author":"N. T. Huong","year":"2006","unstructured":"Huong N T, Lan N T, Cobelens F G, et al 2006 Antituberculosis drug resistance in the south of Vietnam: prevalence and trends; J. Infect. Dis.\n194 1226\u20131232","journal-title":"J. Infect. Dis."},{"key":"78_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJM199309093291108","volume":"329","author":"M. D. Iseman","year":"1993","unstructured":"Iseman M D 1993 Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med.\n329 784\u2013791","journal-title":"N. Engl. J. Med."},{"key":"78_CR29","first-page":"924","volume":"84","author":"W. Jacqui","year":"2006","unstructured":"Jacqui W 2006 Southern Africa is moving swiftly to combat the threat of XDR-TB; Bull. WHO\n84 924\u2013925","journal-title":"Bull. WHO"},{"key":"78_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/clinids\/19.1.1","volume":"19","author":"R. F. Jacaban","year":"1994","unstructured":"Jacaban R F 1994 Multiple drug Resstant Tuberculosis; Clin. Infect. Dis.\n19 1\u201310","journal-title":"Clin. Infect. Dis."},{"key":"78_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/524017","volume":"46","author":"C. Y. Jeon","year":"2008","unstructured":"Jeon C Y, Hwang S H, Min J H, et al 2008 Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital; Clin. Infect. Dis.\n46 42\u201349","journal-title":"Clin. Infect. Dis."},{"key":"78_CR32","first-page":"105","volume":"45","author":"J. Johnson","year":"2003","unstructured":"Johnson J, Kagal A and Bharadwaj R 2003 Factors associated with drug resistance in pulmonary tuberculosis; Indian J. Chest Dis. Allied Sci.\n45 105\u2013109","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"78_CR33","first-page":"760","volume":"8","author":"K. M. Kam","year":"2004","unstructured":"Kam K M and Yip C W 2004 Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995\u20132002, after the implementation of DOTS-plus; Int. J. Tuberc. Lung Dis.\n8 760\u2013766","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1172\/JCI11426","volume":"107","author":"M. Kato-Maeda","year":"2001","unstructured":"Kato-Maeda M, Bifani P J, Krieswirth B N, et al 2001 The nature and consequence of genetic variability in Mycobacterium tuberculosis; J. Clin. Invest.\n107 533\u2013537","journal-title":"J. Clin. Invest."},{"key":"78_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1101\/gr.166401","volume":"11","author":"M. Kato-Maeda","year":"2001","unstructured":"Kato-Maeda, M, Rhee J T, Gingeras T R, et al 2001 Comparing genomes within the species Mycobacterium tuberculosis; Genome Res.\n11 547\u2013555","journal-title":"Genome Res."},{"key":"78_CR36","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/522537","volume":"45","author":"H. R. Kim","year":"2007","unstructured":"Kim H R, Hwang S S, Kim H J, et al 2007 Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis; Clin. Infect. Dis.\n45 1290\u20131295","journal-title":"Clin. Infect. Dis."},{"key":"78_CR37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(05)70196-3","volume":"365","author":"V. Leimane","year":"2005","unstructured":"Leimane V, Rickstina V, Holtz T H, et al 2005 Clinical outcome of individualized treatment of multidrug resistant tuberculosis in Latvia: A retrospective cohort study; Lancet\n365 318\u2013326","journal-title":"Lancet"},{"key":"78_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1086\/507542","volume":"43","author":"M. R. Masjedi","year":"2006","unstructured":"Masjedi M R, Farnia P, Sorooch S, et al 2006 Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran; Clin. Infect. Dis.\n43 841\u2013847","journal-title":"Clin. Infect. Dis."},{"key":"78_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1586\/14787210.5.5.857","volume":"5","author":"A. Matteelli","year":"2007","unstructured":"Matteelli A, Migliori G B, Cirillo D, et al 2007 Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control; Exp. Rev. Anti Infect. Ther.\n5 857\u2013871","journal-title":"Exp. Rev. Anti Infect. Ther."},{"key":"78_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1183\/09031936.00001307","volume":"29","author":"G. B. Migliori","year":"2007","unstructured":"Migliori G B, Loddenkemper R, Blasi F, et al 2007a 125 years after Robert Koch\u2019s discovery of the tubercle bacillus: the new XDR-TB threat. Is \u201cscience\u201d enough to tackle the epidemic?; Eur. Respir. J.\n29 423\u2013427","journal-title":"Eur. Respir. J."},{"key":"78_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid1305.070200","volume":"13","author":"G. Migliori","year":"2007","unstructured":"Migliori G, Ortman J, Giardi E, et al 2007b Extensively drug-resistant tuberculosis, Italy and Germany; Emerg. Infect. Dis.\n13 1\u20134","journal-title":"Emerg. Infect. Dis."},{"key":"78_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa022928","volume":"348","author":"C. Mitnick","year":"2003","unstructured":"Mitnick C, Bayona J, Palacios E, et al 2003 Community-based therapy for multidrug- resistant tuberculosis in Lima, Peru; N. Engl. J. Med.\n348 119\u2013128","journal-title":"N. Engl. J. Med."},{"key":"78_CR43","first-page":"99","volume":"12","author":"C. K. Mlambo","year":"2008","unstructured":"Mlambo C K, Warren R M, Poswa X, et al 2008 Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa; Int. J. Tuberc. Lung Dis.\n12 99\u2013104","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR44","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3201\/eid1309.070443","volume":"13","author":"R. Mondal","year":"2007","unstructured":"Mondal R and Jain A 2007 Extensively Drug-Resistant Mycobacterium tuberculosis, India; Emerg. Infect. Dis.\n13 1429\u20131431","journal-title":"Emerg. Infect. Dis."},{"key":"78_CR45","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","volume":"363","author":"J. S. Mukherjee","year":"2004","unstructured":"Mukherjee J S, Rich M L, Socci AR, et al 2004 Programmes and principles in treatment of multidrug- resistant tuberculosis; Lancet\n363 474\u2013481","journal-title":"Lancet"},{"key":"78_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1749-6632.2001.tb11366.x","volume":"953","author":"A. Mwinga","year":"2001","unstructured":"Mwinga A 2001 Drug resistant tuberculosis in Africa; Ann. N. Y. Acad. Sci.\n953 106\u2013112","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"78_CR47","first-page":"277","volume":"120","author":"J. P. Narain","year":"2004","unstructured":"Narain J P and Lo Y R 2004 Epidemiology of HIV-TB in Asia; Indian J. Med. Res.\n120 277\u2013289","journal-title":"Indian J. Med. Res."},{"key":"78_CR48","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3201\/eid1209.051618","volume":"12","author":"E. Nathanson","year":"2006","unstructured":"Nathanson E, Lambregts-van Wezenbeek C, Rich M L, et al 2006 Multidrug-resistant tuberculosis management in resource-limited settings; Emerg. Infect. Dis.\n12 1389\u20131397","journal-title":"Emerg. Infect. Dis."},{"key":"78_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldh047","volume":"73\u201374","author":"L. P. Ormerod","year":"2005","unstructured":"Ormerod L P 2005 Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment; Br. Med. Bull.\n73\u201374 17\u201324","journal-title":"Br. Med. Bull."},{"key":"78_CR50","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S0198-8859(02)00532-3","volume":"63","author":"M. H. Park","year":"2002","unstructured":"Park M H, Song E Y, Park H J, et al 2002 HLA-DRB1 and DQB1 gene polymorphism is associated with multidrug-resistant tuberculosis in Korean patients; Hum. Immunol.\n63 S33","journal-title":"Hum. Immunol."},{"key":"78_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1164\/ajrccm.153.1.8542137","volume":"153","author":"M. M. Park","year":"1996","unstructured":"Park M M, Davis A L, Schluger N W, et al 1996 Outcome of MDRTB patients, 1983\u20131993. Prolonged survival with appropriate therapy; Am. J. Respir. Crit. Care Med.\n153 317\u2013324","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78_CR52","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1086\/522987","volume":"45","author":"M. Pillay","year":"2007","unstructured":"Pillay M and Sturm A W 2007 Evolution of the extensively drug-resistant F15\/LAM4\/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa; Clin. Infect. Dis.\n45 1409\u20131414","journal-title":"Clin. Infect. Dis."},{"key":"78_CR53","first-page":"121","volume":"52","author":"R. Prasad","year":"2005","unstructured":"Prasad R 2005 MDR TB: Current Status; Indian J. Tuberc.\n52 121\u2013131","journal-title":"Indian J. Tuberc."},{"key":"78_CR54","first-page":"3","volume":"8","author":"R. Prasad","year":"2007","unstructured":"Prasad R and Garg R 2007 XDR-TB: An emerging threat; Chest India\n8 3\u20134","journal-title":"Chest India"},{"key":"78_CR55","first-page":"895","volume":"6","author":"R. Prasad","year":"2002","unstructured":"Prasad R, Nautiyal R G, Mukherji P K, et al 2002 Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India?; Int. J. Tuberc. Lung Dis.\n6 895\u2013902","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR56","first-page":"1012","volume":"8","author":"S. S. Rajbhandary","year":"2004","unstructured":"Rajbhandary S S, Marks S M and Bock N N 2004 Cost of patients hospitalized for multidrug resistant tuberculosis; Int. J. Tuberc. Lung Dis.\n8 1012\u20131016","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR57","first-page":"33","volume":"51","author":"S. P. Rai","year":"2004","unstructured":"Rai S P and Panda B N 2004 Outcome in Multidrug Resistant Tuberculosis patients with ambulatory treatment; Indian J. Tuberc.\n51 33\u201336","journal-title":"Indian J. Tuberc."},{"key":"78_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S. Ramaswamy","year":"1998","unstructured":"Ramaswamy S and Musser J M 1998 Molecular genetic basis of anti-microbial agent resistance in Mycobacterium tuberculosis: 1998 update; Tuber. Lung Dis.\n79 3\u201329","journal-title":"Tuber. Lung Dis."},{"key":"78_CR59","first-page":"S77","volume":"9","author":"S. N. Shah","year":"2005","unstructured":"Shah S N, Wright A and Drobniewski F 2005 Extreme drug resistance in tuberculosis (\u201cXDR-TB\u201d): global survey of supranational reference laboratories for Mycobacterium tuberculosis with resistance to second-line drugs; Int. J. Tuberc. Lung Dis. (Suppl 1)\n9 S77","journal-title":"Int. J. Tuberc. Lung Dis. (Suppl 1)"},{"key":"78_CR60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3201\/eid1303.061400","volume":"13","author":"S. N. Shah","year":"2007","unstructured":"Shah S N, Wright, A, Bai H G, et al 2007 Worldwide emergence of extensively drug-resistant tuberculosis; Emer. Infect. Dis.\n13 380\u2013387","journal-title":"Emer. Infect. Dis."},{"key":"78_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0012-3692(15)50981-1","volume":"130","author":"S. K. Sharma","year":"2006","unstructured":"Sharma S K and Mohan A 2006 Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control; Chest\n130 261\u2013272","journal-title":"Chest"},{"key":"78_CR62","first-page":"354","volume":"120","author":"S. K. Sharma","year":"2004","unstructured":"Sharma S K and Mohan A 2004 Multidrug-resistant tuberculosis; Indian J. Med. Res.\n120 354\u2013376","journal-title":"Indian J. Med. Res."},{"key":"78_CR63","first-page":"157","volume":"101","author":"S. K. Sharma","year":"2003","unstructured":"Sharma S K and Mohan A 2003 Scientific basis of directly observed treatment, short course (DOTS); J. Indian Med. Assoc.\n101 157\u2013158,166","journal-title":"J. Indian Med. Assoc."},{"key":"78_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1567-1348(03)00086-8","volume":"3","author":"S. K. Sharma","year":"2003","unstructured":"Sharma S K, Turaga K K, Balamurugan A, et al 2003 Clinical and genetic risk factors for the development of multidrug-resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study; Infect. Genet. Evol.\n3 183\u2013188","journal-title":"Infect. Genet. Evol."},{"key":"78_CR65","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1097\/QAD.0b013e3282f125c9","volume":"21","author":"S. Singh","year":"2008","unstructured":"Singh S, Sankar M M and Gopinath K 2008 High rate of extensively drug-resistant tuberculosis in Indian AIDS patients; AIDS\n21 2345\u20132347","journal-title":"AIDS"},{"key":"78_CR66","volume-title":"The STOP TB strategy: building on and enhancing DOTS to meet the TB-related millennium development goals","author":"T. B. Stop","year":"2006","unstructured":"Stop T B Partnership 2006 The STOP TB strategy: building on and enhancing DOTS to meet the TB-related millennium development goals (Geneva: World Health Organization)"},{"key":"78_CR67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1056\/NEJM200107193450303","volume":"345","author":"K. Tahaoglu","year":"2001","unstructured":"Tahaoglu K, Torun T, Sevim T, et al 2001 The treatment of multidrug-resistant tuberculosis in Turkey; N. Engl. J. Med.\n345 170\u2013174","journal-title":"N. Engl. J. Med."},{"key":"78_CR68","first-page":"117","volume":"54","author":"A. Thomas","year":"2007","unstructured":"Thomas A, Ramachandran R, Rehaman F, et al 2007 Management of multidrug resistance tuberculosis in the field: Tuberculosis Research Centre experience; Indian J. Tuberc.\n54 117\u2013124","journal-title":"Indian J. Tuberc."},{"key":"78_CR69","first-page":"573","volume":"77","author":"H. Tomioka","year":"2002","unstructured":"Tomioka H 2002 Prospects for development of new antituberculous drug; Kekkaku\n77 573\u2013584","journal-title":"Kekkaku"},{"key":"78_CR70","first-page":"753","volume":"81","author":"H. Tomioka","year":"2006","unstructured":"Tomioka H and Namba K 2006 Development of antituberculous drugs: current status and future prospects; Kekkaku\n81 753\u2013774","journal-title":"Kekkaku"},{"key":"78_CR71","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1472-9792(02)00073-2","volume":"83","author":"M. Uplekar","year":"2003","unstructured":"Uplekar M 2003 Involving private health care providers in delivery of TB care: Global Strategy; Tuberculosis\n83 156\u2013164","journal-title":"Tuberculosis"},{"key":"78_CR72","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0041-3879(91)90055-W","volume":"72","author":"M. W. Uplekar","year":"1991","unstructured":"Uplekar M W and Shepard D S 1991 Treatment of tuberculosis by private general practiceners in India; Tubercle\n72 284\u2013290","journal-title":"Tubercle"},{"key":"78_CR73","first-page":"560","volume":"8","author":"A. Deum Van","year":"2004","unstructured":"Van Deum A, Salim M A, Das A P, Bastian I and Potales F 2004 Results of a standardized regimen for multidrug resistant tuberculosis in Bangladesh; Int. J. Tuberc. Lung Dis.\n8 560\u2013567","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"78_CR74","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0962-8479(92)90064-Q","volume":"73","author":"K. Weyer","year":"1992","unstructured":"Weyer K and Kleeberg H H 1992 Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement; Tuber. Lung Dis.\n73 106\u2013112","journal-title":"Tuber. Lung Dis."},{"key":"78_CR75","unstructured":"World Health Organization Report 2008 Global Tuberculosis Control pp 109\u2013112"},{"key":"78_CR76","first-page":"430","volume":"81","author":"World Health Organization","year":"2006","unstructured":"World Health Organization 2006 Extensively drug-resistant tuberculosis (XDR.TB): recommendations for prevention and control; Weekly Epidemiol. Rec.\n81 430\u2013432","journal-title":"Weekly Epidemiol. Rec."}],"container-title":["Journal of Biosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12038-008-0078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12038-008-0078-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12038-008-0078-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12038-008-0078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:50:05Z","timestamp":1559429405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12038-008-0078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s12038-008-0078-8","relation":{},"ISSN":["0250-5991","0973-7138"],"issn-type":[{"value":"0250-5991","type":"print"},{"value":"0973-7138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}